Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Do Hedge Funds and Insiders Love Integra Lifesciences Holdings Corp (IART)?

Page 1 of 2

If you were to ask many market players, hedge funds are viewed as useless, old investment vehicles of an era lost to time. Although there are over 8,000 hedge funds in operation in present day, this site aim at the top tier of this group, about 525 funds. Analysts calculate that this group oversees the majority of the hedge fund industry’s total capital, and by tracking their best equity investments, we’ve figured out a number of investment strategies that have historically outstripped the S&P 500. Our small-cap hedge fund strategy outstripped the S&P 500 index by 18 percentage points per year for a decade in our back tests, and since we’ve started sharing our picks with our subscribers at the end of August 2012, we have outperformed the S&P 500 index by 33 percentage points in 11 months (explore the details and some picks here).

Integra Lifesciences Holdings Corp

Equally as necessary, bullish insider trading sentiment is a second way to look at the investments you’re interested in. Obviously, there are lots of stimuli for an insider to cut shares of his or her company, but only one, very obvious reason why they would buy. Various academic studies have demonstrated the market-beating potential of this method if piggybackers understand what to do (learn more here).

Keeping this in mind, we’re going to analyze the latest info for Integra Lifesciences Holdings Corp (NASDAQ:IART).

Hedge fund activity in Integra Lifesciences Holdings Corp (NASDAQ:IART)

At the end of the second quarter, a total of 7 of the hedge funds we track held long positions in this stock, a change of -46% from the first quarter. With the smart money’s capital changing hands, there exists a select group of notable hedge fund managers who were increasing their holdings significantly.

According to our 13F database, Ken Fisher’s Fisher Asset Management had the most valuable position in Integra Lifesciences Holdings Corp (NASDAQ:IART), worth close to $22.2 million, accounting for 0.1% of its total 13F portfolio. Coming in second is Kevin Kotler of Broadfin Capital, with a $18.4 million position; the fund has 3.6% of its 13F portfolio invested in the stock. Some other hedge funds that are bullish include David Dreman’s Dreman Value Management, James E. Flynn’s Deerfield Management and Ken Griffin’s Citadel Investment Group.

As Integra Lifesciences Holdings Corp (NASDAQ:IART) has faced a fall in interest from the entirety of the hedge funds we track, it’s easy to see that there lies a certain “tier” of funds that slashed their positions entirely heading into Q2. Intriguingly, Phill Gross and Robert Atchinson’s Adage Capital Management cut the largest position of the “upper crust” of funds we monitor, comprising close to $13.9 million in stock, and Mark Broach of Manatuck Hill Partners was right behind this move, as the fund cut about $7.5 million worth. These transactions are important to note, as total hedge fund interest fell by 6 funds heading into Q2.

How are insiders trading Integra Lifesciences Holdings Corp (NASDAQ:IART)?

Insider buying made by high-level executives is most useful when the company in question has experienced transactions within the past half-year. Over the latest half-year time frame, Integra Lifesciences Holdings Corp (NASDAQ:IART) has experienced zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll go over the relationship between both of these indicators in other stocks similar to Integra Lifesciences Holdings Corp (NASDAQ:IART). These stocks are HeartWare International Inc (NASDAQ:HTWR), ICU Medical, Incorporated (NASDAQ:ICUI), Insulet Corporation (NASDAQ:PODD), Endologix, Inc. (NASDAQ:ELGX), and DexCom, Inc. (NASDAQ:DXCM). This group of stocks belong to the medical instruments & supplies industry and their market caps match IART’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!